Growth and weight gain of prepubertal children after cardiac transplantation

Renuka E Peterson1, Gregory S Perens, Juan C Alejos

  • 1Department of Pediatrics, Children's Hospital of Orange County, Orange County, CA, USA.

Insights

Pediatric heart transplant recipients experienced significant weight and BMI gains within six months, but linear growth remained unchanged. Steroid treatment duration negatively impacted height changes, while younger transplant age correlated with better height outcomes.

Area of Science:

  • Pediatric Cardiology
  • Transplantation Medicine
  • Growth and Development

Background:

  • Pediatric heart transplantation (OHT) is a life-saving procedure.
  • Understanding post-transplant growth is crucial for long-term patient outcomes.
  • Somatic growth changes, including weight, height, and BMI, require careful monitoring after OHT.

Purpose of the Study:

  • To evaluate changes in weight, height, and BMI Z scores after pediatric heart transplantation.
  • To identify factors influencing somatic growth changes in children post-OHT.
  • To assess the long-term impact of OHT on growth parameters.

Main Methods:

  • Retrospective evaluation of 46 pediatric heart transplant recipients (<11 years old).
  • Analysis of changes in weight, height, and BMI Z scores at baseline and up to two years post-transplant.
  • Multivariate analysis to identify predictors of growth changes, including steroid treatment duration and age at transplant.

Main Results:

  • Significant increases in weight and BMI Z scores were observed at six months post-OHT (p < 0.001).
  • No significant changes in height Z scores were noted at six months, one year, or two years post-OHT.
  • 17% of patients became overweight (BMI Z score > 2) within two years; steroid treatment duration predicted negative height change, while younger age at transplant predicted positive height change.

Conclusions:

  • Pediatric heart transplant recipients show significant weight and BMI gain but limited linear growth catch-up.
  • Increased BMI post-transplant can lead to overweight and obesity, necessitating monitoring.
  • Steroid therapy duration and age at transplant are key factors influencing post-transplant linear growth.

Related Concept Videos

Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...